These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24854540)

  • 1. Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases.
    Dong Y; Harrington BS; Adams MN; Wortmann A; Stephenson SA; Lisle J; Herington A; Hooper JD; Clements JA
    Biol Chem; 2014 Sep; 395(9):977-90. PubMed ID: 24854540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
    Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for tissue kallikrein-related peptidases in human cervico-vaginal physiology.
    Shaw JL; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):681-8. PubMed ID: 18627298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the extended substrate specificity of kallikrein 1-related peptidases.
    Borgoño CA; Gavigan JA; Alves J; Bowles B; Harris JL; Sotiropoulou G; Diamandis EP
    Biol Chem; 2007 Nov; 388(11):1215-25. PubMed ID: 17976015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue kallikrein proteolytic cascade pathways in normal physiology and cancer.
    Pampalakis G; Sotiropoulou G
    Biochim Biophys Acta; 2007 Sep; 1776(1):22-31. PubMed ID: 17629406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).
    Ramsay AJ; Reid JC; Adams MN; Samaratunga H; Dong Y; Clements JA; Hooper JD
    Biol Chem; 2008 Jun; 389(6):653-68. PubMed ID: 18627286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of hepatocyte growth factor activator zymogen (pro-HGFA) by human kallikrein 1-related peptidases.
    Mukai S; Fukushima T; Naka D; Tanaka H; Osada Y; Kataoka H
    FEBS J; 2008 Mar; 275(5):1003-17. PubMed ID: 18221492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
    Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
    Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the kallikrein-related peptidases for drug development.
    Sotiropoulou G; Pampalakis G
    Trends Pharmacol Sci; 2012 Dec; 33(12):623-34. PubMed ID: 23089221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting kallikrein-related peptidases in prostate cancer.
    Mavridis K; Avgeris M; Scorilas A
    Expert Opin Ther Targets; 2014 Apr; 18(4):365-83. PubMed ID: 24571737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.
    Linardoutsos D; Gazouli M; Machairas A; Bramis I; Zografos GC
    J BUON; 2014; 19(1):53-9. PubMed ID: 24659643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KLKs and their hormone-like signaling actions: a new life for the PSA-KLK family.
    Hollenberg MD
    Biol Chem; 2014 Sep; 395(9):915-29. PubMed ID: 25153380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions.
    Eissa A; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):669-80. PubMed ID: 18627299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative functions of tissue kallikrein-related peptidases in vaginal fluid.
    Muytjens CM; Vasiliou SK; Oikonomopoulou K; Prassas I; Diamandis EP
    Nat Rev Urol; 2016 Oct; 13(10):596-607. PubMed ID: 27603220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases.
    Schremmer-Danninger E; Naidoo S; Neuhof C; Valeske K; Snyman C; Sander C; Bhoola KD; Neuhof H
    Biol Chem; 2004 Nov; 385(11):1069-76. PubMed ID: 15576327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy.
    Silva LM; Clements JA
    Expert Rev Proteomics; 2017 Dec; 14(12):1119-1130. PubMed ID: 29025353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interrelationships between the kallikrein-related peptidases family and the classical kinin system in the human neutrophil.
    Ehrenfeld P; Bhoola KD; Matus CE; Figueroa CD
    Biol Chem; 2018 Sep; 399(9):925-935. PubMed ID: 29883315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms.
    Koumandou VL; Scorilas A
    PLoS One; 2013; 8(7):e68074. PubMed ID: 23874499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative kallikrein substrates and their (patho)biological functions.
    Yu Y; Prassas I; Diamandis EP
    Biol Chem; 2014 Sep; 395(9):931-43. PubMed ID: 24854536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation profiles and regulatory cascades of the human kallikrein-related peptidases.
    Yoon H; Laxmikanthan G; Lee J; Blaber SI; Rodriguez A; Kogot JM; Scarisbrick IA; Blaber M
    J Biol Chem; 2007 Nov; 282(44):31852-64. PubMed ID: 17823117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.